Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation
- PMID: 6609729
Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation
Abstract
A series of monoclonal antibodies that define B cell restricted and associated antigens was utilized in an attempt to characterize tumors of B lineage and to relate these tumors to B cell differentiative stages. Antigens that were previously shown to be B cell restricted on normal B lymphocytes were similarly expressed only on B cell malignancies. In contrast, antigens that were B cell associated were also found on tumors of other lineages. Moreover, on the basis of cell surface phenotypes, tumors of B cell origin were divided into three major subgroups, which corresponded to the level of differentiation of the malignant tumor cell: pre-B cell stage (non-T acute lymphoblastic leukemia and chronic myelocytic leukemia in lymphoid blast crisis); the mid-B cell stage (chronic lymphocytic leukemia, poorly differentiated lymphomas); and secretory B cell stage (large cell lymphomas and plasma cell tumors). A hypothetical model is derived that relates the malignant B cell to its normal cellular counterpart on the basis of cell surface expression of this panel of B cell-restricted and B cell-associated antigens.
Similar articles
-
A unique cell surface antigen identifying lymphoid malignancies of B cell origin.J Clin Invest. 1981 Jan;67(1):134-40. doi: 10.1172/JCI110005. J Clin Invest. 1981. PMID: 6969730 Free PMC article.
-
B-cell malignancies and differentiation antigens defined with monoclonal antibodies.Jpn J Clin Oncol. 1983 Sep;13(3):517-31. Jpn J Clin Oncol. 1983. PMID: 6417375
-
[Diagnosis and classification of hematologic tumors using anti-lymphocyte monoclonal antibodies].Gan To Kagaku Ryoho. 1983 Feb;10(2 Pt 2):551-8. Gan To Kagaku Ryoho. 1983. PMID: 6603817 Japanese.
-
Cell surface markers in leukemia: biological and clinical correlations.Crit Rev Oncol Hematol. 1985;2(3):209-60. doi: 10.1016/s1040-8428(85)80003-2. Crit Rev Oncol Hematol. 1985. PMID: 3013441 Review.
-
Immunologic classification of leukemia and lymphoma.Blood. 1986 Jul;68(1):1-31. Blood. 1986. PMID: 2941082 Review.
Cited by
-
Immune deficiencies in chronic lymphocytic leukemia and multiple myeloma.Clin Rev Allergy. 1992 Spring-Summer;10(1-2):39-58. doi: 10.1007/978-1-4612-0417-6_4. Clin Rev Allergy. 1992. PMID: 1606523 Review. No abstract available.
-
A c-Myc and surface CD19 signaling amplification loop promotes B cell lymphoma development and progression in mice.J Immunol. 2012 Sep 1;189(5):2318-25. doi: 10.4049/jimmunol.1201000. Epub 2012 Jul 23. J Immunol. 2012. PMID: 22826319 Free PMC article.
-
Expression of CD34 on human B cell precursors.Clin Exp Immunol. 1991 Jul;85(1):168-73. doi: 10.1111/j.1365-2249.1991.tb05699.x. Clin Exp Immunol. 1991. PMID: 1712682 Free PMC article.
-
Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies.Clin Exp Immunol. 1987 Oct;70(1):192-200. Clin Exp Immunol. 1987. PMID: 3319299 Free PMC article.
-
Bioengineering a unique deimmunized bispecific targeted toxin that simultaneously recognizes human CD22 and CD19 receptors in a mouse model of B-cell metastases.Mol Cancer Ther. 2010 Jun;9(6):1872-83. doi: 10.1158/1535-7163.MCT-10-0203. Epub 2010 Jun 8. Mol Cancer Ther. 2010. PMID: 20530709 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
